Company Information

Company Takeda Pharmaceutical Company Limited
Pharmaceuticals & Biotechnology
Publicly Listed
Global Compact Status:
Participant Since
31 March 2009
Letter of Commitment
Next Communication on Progress (COP) due on:
31 December 2023

Financial Information

Non-Financial Information

Affiliated Subsidiaries

Country Company Name
India Baxalta Bioscience India Pvt Limited

Communication On Progress

Published On Title Level/Status
2022-12-16 2022 Annual Integrated Report Active
2021-12-20 2021 Annual Integrated Report Learner
2020-12-25 2020 Sustainability Report Active
2020-01-14 Sustainable Value Report 2019 Active
31-Jul-2019 Grace Letter Not applicable
2018-10-30 Sustainable Value Report 2018 Advanced
2017-10-30 Sustainable Value Report 2017 Advanced
2016-10-31 Communication on Progress Advanced
2015-11-02 Communication on Progress Advanced
2014-11-04 Communication on Progress Advanced
2013-11-10 Communication on Progress Advanced
2012-11-09 Communication on Progress Advanced
2011-12-08 Annual Report 2011/ CSR Databook 2011 Advanced
2010-12-08 2010 Communication on Progress Not applicable
2009-12-08 2009 CSR Databook Not applicable

Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.

Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.